BOT 2.78% 35.0¢ botanix pharmaceuticals ltd

Churn churn churn, page-3

  1. 183 Posts.
    lightbulb Created with Sketch. 92
    Expect to see appreciation in a couple of months, probably after those magnificent equines hit the turf at Flemington. First patients for BTX1503 's Phase2 trial were enrolled in late June with early (?) July start, plus a 12 weeks period to Change from Baseline, it'd be at least mid October before leaked outcomes may see a correlation in the sp.
    In any case the Estimated Primary Completion Date is next February and I'm happy to hold till then.

    https://clinicaltrials.gov/ct2/show/NCT03573518?term=BTX1503&recrs=ab&cond=Acne&rank=1

    ....from the investigator's meeting:

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.010(2.78%)
Mkt cap ! $707.4M
Open High Low Value Volume
36.0¢ 37.0¢ 33.5¢ $2.103M 6.050M

Buyers (Bids)

No. Vol. Price($)
2 32406 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 234417 5
View Market Depth
Last trade - 16.10pm 02/12/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.